LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ)

SEC filing

LIGAND PHARMACEUTICALS INCORPORATED

LGNDZ · CIK 886163

4 · Oct 6, 2026 · CLO & Secretary Reardon Andrew sold 5,000 shares at $304.07/share ($1.5M); exercised options for 680 shares

CLO & Secretary Reardon Andrew sold 5,000 shares at $304.07/share ($1.5M); exercised options for 680 shares

FORM 4

xslF345X06/wk-form4_1791318933.xmlSEC.gov

Graphics and non-inline formats (not embedded below).